Blanket Purchase Agreement HT941024A0010

Award Date 7/10/24
Last Date to Order 7/9/29
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, to provide radiopharmaceuticals to military treatment facilities. The ceiling value of the BPA is $2,000,000, with an ultimate completion date of September 30, 2025. Petnet Solutions, a manufacturer and distributor of specialized radioactive tracers and imaging agents used in positron emission tomography (PET) and computed tomography (CT)...
This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
The Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Pharmalucence, Inc. as a single-award contract with a potential value of $1,250,000. The BPA aims to procure radiopharmaceutical supplies for Tripler Army Medical Center in Hawaii over a five-year period of performance from May 2021 through April 2026. Under the BPA, Pharmalucence will provide a range of radiopharmaceutical products to support nuclear medicine diagnostic imaging and related clinical...
The Defense Health Agency (DHA) has awarded a Blanket Purchase Agreement (BPA) to Medi-Physics, Inc., a subsidiary of General Electric Company (GE), to provide radiopharmaceuticals and supplies to military treatment facilities nationwide. The contract has a potential value of $1 million and a period of performance from October 1, 2020 through September 30, 2025. Under this BPA, Medi-Physics will deliver a range of radioactive tracers, medical isotopes, and diagnostic imaging agents used in...
This Blanket Purchase Agreement was awarded by the Department of the Army Medical Command to Medi-Physics, Inc. to provide radiopharmaceutical supplies to Tripler Army Medical Center in Hawaii. The single award BPA has a potential value of $1.25 million and a period of performance through April 2026. The BPA facilitates orders for radiopharmaceutical supplies needed to support nuclear medicine diagnostic imaging services at Tripler Army Medical Center. As the primary provider of healthcare to...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Trillamed LLC, a service-disabled veteran-owned small business (SDVOSB), to provide a wide range of medical and facility products for the VA's Medical/Surgical Prime Vendor (MSPV) Program. The BPA has an estimated ceiling value of $1 and a period of performance through April 2026. The original solicitation covered the establishment of multiple BPAs to supply an estimated 49,000 types of...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian federal agency, to Advanced Accelerator Applications USA Inc., a large, foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $23.4 million single-award BPA is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of February 3, 2025. The BPA is for the procurement of LOCAMETZ and NETSPOT, two...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) contract to Telix Pharmaceuticals US Inc. for the provision of various radiopharmaceuticals. The single-award BPA has a ceiling value of $4,498,000.00 and a period of performance from October 1, 2023 through September 30, 2028. Under this BPA, the VA VHA has issued a $910,000.00 firm fixed price BPA Call Order to Telix Pharmaceuticals US Inc. for the base period from...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 6 awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Trillamed LLC, a service-disabled veteran-owned small business (SDVOSB), for the supply of PET radiopharmaceuticals. Under this IDIQ contract, VISN 6 has issued multiple firm fixed-price delivery orders to Trillamed for the provision of PET radioisotopes to support nuclear imaging procedures at VA...
The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...

This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency to Trillamed LLC, a veteran-owned small business, to provide positron emission tomography (PET) radiopharmaceuticals to the Naval Medical Center San Diego. The $1,145,770 single-award contract has a period of performance through July 2029. Trillamed has extensive experience providing a variety of medical equipment, supplies, and related services to federal agencies, including the VA, DoD, and other healthcare organizations. The scope of this BPA includes the delivery of PET radiopharmaceuticals to support the imaging needs at the Naval Medical Center. No additional details were provided regarding the specific types or quantities of radiopharmaceuticals to be delivered. This contract represents one of multiple indefinite delivery contracts held by Trillamed with various government agencies, demonstrating the company's ability to deliver a wide range of medical products and services to meet the specialized procurement needs of its federal customers.

Generated 10/8/24, 9:04 AM